Spectrum Pharmaceuticals Stock Price

-0.0236 (-5.27%)
Upgrade to Real-Time
Regular Market
Volume 1,433,390
Bid Price 0.4224
Ask Price 0.4255
News -
Day High 0.4422


52 Week Range


Day Low 0.4155
Company Name Stock Ticker Symbol Market Type
Spectrum Pharmaceuticals Inc SPPI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0236 -5.27% 0.424 11:17:12
Open Price Low Price High Price Close Price Prev Close
0.4422 0.4155 0.4422 0.4476
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,530 1,433,390 $ 0.4271255 $ 612,237 - 0.41 - 2.45
Last Trade Time Type Quantity Stock Price Currency
11:17:11 400 $ 0.424 USD


Draw Mode:

Spectrum Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 79.78M 188.16M 186.63M $ - $ - -1.02 -0.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 513.68k 2.90%

more financials information »

Spectrum Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SPPI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.44840.4820.410.44642013,600,902-0.0244-5.44%
1 Month1.251.550.410.9387459,291,359-0.826-66.08%
3 Months0.78631.570.411.024,821,328-0.3623-46.08%
6 Months1.411.570.410.96606183,440,643-0.986-69.93%
1 Year2.082.450.411.143,985,255-1.66-79.62%
3 Years7.9310.570.412.472,819,247-7.51-94.65%
5 Years14.8225.290.415.472,195,600-14.40-97.14%

Spectrum Pharmaceuticals Description

Spectrum Pharmaceuticals Inc operates in the healthcare sector in the United States. It is a biopharmaceutical company with a primary strategy comprised of acquiring, developing and commercializing novel and targeted oncology therapies. Eflapegrastim and Poziotinib are it's current drugs in last stage development. Eflapegrastim is a novel long-acting granulocyte colony-stimulating factor ("G-CSF") for the treatment of chemotherapy-induced neutropenia and Poziotinib is a novel irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer ("NSCLC") tumors with various mutations.
Your Recent History
Spectrum P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221005 15:32:18